Sun Pharmaceutical Industries Inc. is recalling 2,016 bottles of Bupropion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg. This prescription medication, which is used to treat depression, is being recalled because it failed dissolution testing, meaning the tablets may not release the medication at the correct rate. No injuries or incidents have been reported in connection with this recall.
When a medication fails to dissolve as specified, the patient may not receive the intended dose at the proper time, which can lead to ineffective treatment of their medical condition.
You have 2 options:
Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Limited, Gujarat, India
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.